High expression of cIAP1 and cIAP2 was significantly associated with poor prognosis in patients with CRC treated with 5-FU, and further studies revealed that downregulation of cIAP2 effectively enhanced 5-FU sensitivity through the apoptotic pathway (Crawford et al. 2021). The gene discussed is BIRC2; the disease is colorectal carcinoma.